Markets:

Overview

News

Currencies

International

Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

135.55 -0.54 (-0.40%)

Streaming Delayed Price Updated: 11:28 AM EST, Dec 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GeneDx Holdings Corp. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

GeneDx CFO Sells More Than Half of His Shares ↗

July 25, 2025

Via The Motley Fool

Topics Artificial Intelligence

Bragar Eagel & Squire, P.C Continues Investigations on Behalf of Lineage, Proficient Auto, PetMed, and GeneDx and Encourages Investors to Contact the Firm

July 23, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

July 22, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Bragar Eagel & Squire, P.C Continues Investigations on Behalf of CTO Realty, GeneDx, Quantum, and Proficient Auto and Encourages Investors to Contact the Firm

July 21, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

July 18, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Bragar Eagel & Squire, P.C Continues Investigations on Behalf of PetMed, GeneDx, Lineage, and Proficient Auto and Encourages Investors to Contact the Firm

July 14, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

July 14, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

GeneDx to Report Second Quarter 2025 Financial Results on Tuesday, July 29, 2025

July 10, 2025

From GeneDx

Via Business Wire

Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday ↗

July 09, 2025

Via Benzinga

WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

July 07, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

July 02, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains ↗

June 30, 2025

With major rallies and analyst backing, Nektar, Cidara, and GeneDx are drawing interest; will these biopharma firms maintain their growth trajectories?

Via MarketBeat

Expert Outlook: GeneDx Holdings Through The Eyes Of 4 Analysts ↗

June 30, 2025

Via Benzinga

Why GeneDX Stock Surged Higher This Week ↗

June 27, 2025

Via The Motley Fool

WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

June 25, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

GeneDx Announces Publication of SeqFirst Study Demonstrating Need for First Tier Rapid Genomic Testing for Non-Critical Care Pediatric Inpatients in The Journal of Pediatrics

June 25, 2025

From GeneDx

Via Business Wire

Why GeneDx, An IBD 50 Stock, Has Skyrocketed 34% Over The Past Two Days ↗

June 24, 2025

There's a new recommendation on genetic testing for children, and this stock is on the rise.

Via Investor's Business Daily

Carnival Posts Better-Than-Expected Earnings, Joins Liminatus Pharma, Coinbase Global, Uber And Other Big Stocks Moving Higher On Tuesday ↗

June 24, 2025

Via Benzinga

GeneDx Announces American Academy of Pediatrics Recommends Exome and Genome Sequencing as First-Tier Tests for Children with Global Developmental Delay or Intellectual Disability

June 23, 2025

From GeneDx

Via Business Wire

Galatea Bio and Fabric Genomics Partner to Deliver Comprehensive Genetic Testing for Common Diseases

June 23, 2025

From GeneDx

Via Business Wire

GENEDX ALERT: Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. on Behalf of GeneDx Stockholders and Encourages Investors to Contact the Firm

June 17, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Rosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation – WGS

June 12, 2025

From The Rosen Law Firm, P.A.

Via Business Wire

WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Fraud Investigation with the Schall Law Firm

June 11, 2025

From The Schall Law Firm

Via Business Wire

GeneDx to Participate in Upcoming Investor Conferences

May 22, 2025

From GeneDx

Via Business Wire

GeneDx Publishes Pioneering Vision for Applying AI to Genomics to Improve and Expedite Diagnosis of Genetic Disease at Scale

May 22, 2025

From GeneDx

Via Business Wire

Analyst Expectations For GeneDx Holdings's Future ↗

May 09, 2025

Via Benzinga

This National Vision Holdings Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday ↗

May 09, 2025

Via Benzinga

GeneDx Announces Completion of Fabric Genomics Acquisition

May 07, 2025

From GeneDx

Via Business Wire

Why Investors Were Avoiding GeneDx Holdings Stock This Week ↗

May 02, 2025

Via The Motley Fool

Retail Buzz Swirls Around GeneDx As Shares Sink 43% Despite Earnings Beat ↗

April 30, 2025

GeneDx shares plunged 43% despite strong Q1 results and raised guidance, drawing a surge in retail investor interest. The drop followed the company's first sequential test volume decline, which it...

Via Stocktwits

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.